Arkolith/Insider Trading/EIGR/Form 4

Kayne Richard A

10% OwnerEiger BioPharmaceuticals, Inc. (EIGR) · full profile →Form 4 · filed Nov 2, 2023
Net Buying
Open-Market Buys
$73K
Open-Market Sells
$0
Net Open-Market Flow
$73K
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 2, 2023Buy(P)23K$0.30$7K5.4M
Nov 1, 2023Buy(P)100K$0.28$28K5.4M
Oct 31, 2023Buy(P)131K$0.24$31K5.3M
Oct 31, 2023Buy(P)12K$0.26$3K5.1M
Oct 31, 2023Buy(P)12K$0.26$3K5.1M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-23-051263) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML